Equitable Trust’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $753K | Buy |
11,995
+95
| +0.8% | +$6.62K | 0.03% | 260 |
|
|
2025
Q4 | $790K | Hold |
11,900
| – | – | 0.04% | 263 |
|
|
2025
Q3 | $801K | Hold |
11,900
| – | – | 0.04% | 269 |
|
|
2025
Q2 | $1.04M | Hold |
11,900
| – | – | 0.05% | 226 |
|
|
2025
Q1 | $813K | Hold |
11,900
| – | – | 0.05% | 245 |
|
|
2024
Q4 | $925K | Sell |
11,900
-6,343
| -35% | -$470K | 0.05% | 238 |
|
|
2024
Q3 | $1.22M | Sell |
18,243
-396
| -2% | -$32.5K | 0.08% | 185 |
|
|
2024
Q2 | $2.11M | Sell |
18,639
-117
| -0.6% | -$14.8K | 0.15% | 132 |
|
|
2024
Q1 | $2.6M | Sell |
18,756
-657
| -3% | -$82.6K | 0.18% | 115 |
|
|
2023
Q4 | $2.41M | Hold |
19,413
| – | – | 0.18% | 107 |
|
|
2023
Q3 | $1.81M | Sell |
19,413
-8
| -0% | -$902 | 0.15% | 120 |
|
|
2023
Q2 | $2.5M | Buy |
19,421
+117
| +0.6% | +$14.2K | 0.19% | 99 |
|
|
2023
Q1 | $2.24M | Buy |
19,304
+620
| +3% | +$69.4K | 0.18% | 106 |
|
|
2022
Q4 | $2.12M | Sell |
18,684
-932
| -5% | -$102K | 0.17% | 120 |
|
|
2022
Q3 | $1.58M | Sell |
19,616
-3,188
| -14% | -$270K | 0.13% | 140 |
|
|
2022
Q2 | $1.7M | Sell |
22,804
-3,976
| -15% | -$363K | 0.13% | 139 |
|
|
2022
Q1 | $3.43M | Sell |
26,780
-144
| -0.5% | -$15.8K | 0.22% | 100 |
|
|
2021
Q4 | $3.61M | Sell |
26,924
-4,108
| -13% | -$590K | 0.22% | 100 |
|
|
2021
Q3 | $4.24M | Sell |
31,032
-56
| -0.2% | -$7.06K | 0.27% | 96 |
|
|
2021
Q2 | $3.32M | Sell |
31,088
-10,360
| -25% | -$995K | 0.21% | 105 |
|
|
2021
Q1 | $3.72M | Sell |
41,448
-4,232
| -9% | -$397K | 0.28% | 98 |
|
|
2020
Q4 | $4.22M | Sell |
45,680
-1,020
| -2% | -$91.1K | 0.31% | 87 |
|
|
2020
Q3 | $4.81M | Sell |
46,700
-384
| -0.8% | -$40.1K | 0.41% | 68 |
|
|
2020
Q2 | $4.77M | Sell |
47,084
-772
| -2% | -$69.1K | 0.44% | 64 |
|
|
2020
Q1 | $3.22M | Buy |
47,856
+21,856
| +84% | +$1.36M | 0.35% | 79 |
|
|
2019
Q4 | $1.42M | Hold |
26,000
| – | – | 0.14% | 126 |
|
|
2019
Q3 | $970K | Hold |
26,000
| – | – | 0.1% | 148 |
|
|
2019
Q2 | $974K | Hold |
26,000
| – | – | 0.1% | 154 |
|
|
2019
Q1 | $774K | Hold |
26,000
| – | – | 0.09% | 163 |
|
|
2018
Q4 | $779K | Buy |
26,000
+600
| +2% | +$19K | 0.1% | 161 |
|
|
2018
Q3 | $908K | Buy |
+25,400
| New | +$787K | 0.11% | 159 |
|
Other funds holding DXCM
VCM
VPM
Equitable Trust's DXCM Position: Q1 2026 in Review
Equitable Trust increased its DexCom (DXCM) stake by 0.8% in Q1 2026, buying an estimated $6.62K and bringing the position to 11,995 shares worth $753K. The position accounts for 0.03% of the portfolio, ranked #260.
Equitable Trust first reported a position in DXCM in Q3 2018 and has held it in 31 quarters since. The position peaked at $4.81M in Q3 2020. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Equitable Trust held 11,995 shares of DexCom worth $753K as of Q1 2026.
- Equitable Trust bought 95 DexCom shares in Q1 2026, an estimated $6.62K.
- DexCom made up 0.03% of Equitable Trust's portfolio in Q1 2026, its #260 holding.
- Equitable Trust first reported a position in DexCom in Q3 2018 and has held it in 31 quarters since.
- Equitable Trust's DexCom position peaked at $4.81M in Q3 2020.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Equitable Trust's 13F filing for Q1 2026, filed 30 Apr 2026.